Search results (702)
« Back to PublicationsCohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter.
Journal article
Peeters ACD. et al, (2026), Clin Pharmacol Ther, 119, 651 - 659
Frequency and Characteristics of Axial Involvement in Psoriatic Arthritis: Results from the International Multicentre AXIS Study.
Journal article
Coates L. and Torgutalp M., (2026), Annals of the Rheumatic Diseases
Composite and pragmatic measures in psoriatic arthritis: bridging trials and clinical feasibility.
Journal article
Kang J-H. and Coates LC., (2026), Curr Opin Immunol, 99
Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies
Journal article
Gossec L. et al, (2026), Rheumatology
Comparative effectiveness and persistence of ixekizumab and other b/tsDMARDs in patients with PsA from a real-world setting: 12-month results from the PRO-SPIRIT study.
Journal article
Marzo-Ortega H. et al, (2026), RMD Open, 12
Therapeutic Windows Across the Psoriatic Arthritis Spectrum.
Journal article
Kang J-H. and Coates LC., (2026), Rheumatol Ther, 13, 27 - 43
Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials.
Journal article
Gladman DD. et al, (2026), Rheumatol Ther, 13, 213 - 229
Comment on: Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis: Reply.
Journal article
Minikumari Rahulan L. et al, (2026), Rheumatology (Oxford)
Trialblazers: patient-driven redesign of a clinical trial in psoriatic arthritis.
Journal article
Struthers C. et al, (2026), Lancet Rheumatol
Interpretable rheumatoid arthritis scoring via anatomy-aware multiple instance learning
Conference paper
Bo Z. et al, (2026), Applications of Medical Artificial Intelligence: 4th International Workshop, AMAI 2025, Held in Conjunction with MICCAI 2025, Daejeon, South Korea, September 23, 2025, Proceedings, 52 - 62
Drivers of Patients’ Intention To Use Digital Serious Games in Psoriatic Arthritis Care
Preprint
Dias SB. et al, (2026)
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study.
Journal article
Leung Y-Y. et al, (2025), Semin Arthritis Rheum, 77
Development of patient initiated follow up resources for UK rheumatology departments: a co-design study with patient and clinician collaboration
Journal article
Jennings AE. et al, (2025), Lancet Rheumatology
The protocol for a patient-driven on-line prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis (PsA) amongst people living with psoriasis: the HIPPOCRATES Prospective Observational Study (HPOS)
Journal article
Grohmann T. et al, (2025), Therapeutic Advanced in Musculoskeletal Disease
Inhibition of structural damage progression with the selective interleukin-23 inhibitor guselkumab in participants with active PsA: results through week 24 of the phase 3b, randomised, double-blind, placebo-controlled APEX study.
Journal article
Mease PJ. et al, (2025), Ann Rheum Dis, 84, 1983 - 1994